Molecular Human Reproduction, Vol. 9, No. 4, 175-181,
April 2003
© 2003 European Society of Human Reproduction and Embryology
Article |
The molecular basis of cryptorchidism*
Submitted on October 23, 2002; . accepted on December 18, 2002
Institute for Hormone and Fertility Research, University of Hamburg, Grandweg 64, 22529 Hamburg, Germany
1 To whom correspondence should be addressed. e-mail: ivell{at}ihf.de
*This article is dedicated to Professor Freimut Leidenberger on the occasion of his 65th birthday.
Cryptorchidism is the commonest malady to affect newborn male infants. Until recently, the molecular aetiology of this syndrome was unclear. Cryptorchidism may be part of a broader testicular dysgenesis syndrome, wherein a disturbance in steroid hormone metabolism, possibly through a perturbed hypothalamic–pituitary–gonadal axis could be involved. Disturbance may be genetic, or extrinsic through endocrine disruptors. Recently, the role of insulin-like factor-3 (INSL3; alternatively called relaxin-like factor) has been highlighted through the cryptorchid phenotype of mice where genes for either INSL3 or its receptor have been ablated. INSL3 is produced by Leydig cells of the fetal testis and acts upon the gubernacular ligament to retain the gonad in the inguinal region, from which it later passes into the scrotum. INSL3 expression in fetal testis is inhibited by maternal exposure to estrogens. Although to date no mutations have been found in the human INSL3 gene responsible for cryptorchidism, one causative mutation in the INSL3 receptor (LGR8 or GREAT) has been reported. Studies on developmental transcription factors, such as Hoxa-10 in mice, suggest that other specific molecular cascades could also lead to a cryptorchid phenotype. Considering its frequency in newborn children, and the severity of the untreated condition (infertility and often testicular cancer) these new findings should generate new information on possible causes and treatments.
Key words: cryptorchidism/Hoxa-10/INSL3/RLF/steroids/testicular dysgenesis syndrome
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Foresta, D. Zuccarello, A. Garolla, and A. Ferlin Role of Hormones, Genes, and Environment in Human Cryptorchidism Endocr. Rev., August 1, 2008; 29(5): 560 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Nuti, E. Marinari, E. Erdei, M. El-Hamshari, M. G. Echavarria, E. Ars, G. Balercia, M. Merksz, C. Giachini, K. Z. M. Shaeer, et al. The Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 8 Gene T222P Mutation Does Not Cause Cryptorchidism J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 1072 - 1076. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Wilhelm, S. Palmer, and P. Koopman Sex Determination and Gonadal Development in Mammals Physiol Rev, January 1, 2007; 87(1): 1 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Radpour, M. Rezaee, A. Tavasoly, S. Solati, and A. Saleki Association of Long Polyglycine Tracts (GGN Repeats) in Exon 1 of the Androgen Receptor Gene With Cryptorchidism and Penile Hypospadias in Iranian Patients J Androl, January 1, 2007; 28(1): 164 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Novak, L. J. Parry, J. E. Matthews, L. J. Kerchner, K. Indovina, K. Hanley-Yanez, K. D. Doty, D. O. Debrah, S. G. Shroff, and K. P. Conrad Evidence for local relaxin ligand-receptor expression and function in arteries FASEB J, November 1, 2006; 20(13): 2352 - 2362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M Main, J. Toppari, and N. E Skakkebaek Gonadal development and reproductive hormones in infant boys Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S51 - S57. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Rosengren, S. Zhang, F. Lin, N. L. Daly, D. J. Scott, R. A. Hughes, R. A. D. Bathgate, D. J. Craik, and J. D. Wade Solution Structure and Characterization of the LGR8 Receptor Binding Surface of Insulin-like Peptide 3 J. Biol. Chem., September 22, 2006; 281(38): 28287 - 28295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Rajpert-De Meyts Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects Hum. Reprod. Update, May 1, 2006; 12(3): 303 - 323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J.K. Anand-Ivell, V. Relan, M. Balvers, I. Coiffec-Dorval, M. Fritsch, R. A.D. Bathgate, and R. Ivell Expression of the Insulin-Like Peptide 3 (INSL3) Hormone-Receptor (LGR8) System in the Testis Biol Reprod, May 1, 2006; 74(5): 945 - 953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.P. Yuan, D.X. Lin, C.V. Rao, and Z.M. Lei Cryptorchidism in LhrKO animals and the effect of testosterone-replacement therapy Hum. Reprod., April 1, 2006; 21(4): 936 - 942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Bathgate, R. Ivell, B. M. Sanborn, O. D. Sherwood, and R. J. Summers International Union of Pharmacology LVII: Recommendations for the Nomenclature of Receptors for Relaxin Family Peptides. Pharmacol. Rev., March 1, 2006; 58(1): 7 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-M. Suomi, K. M. Main, M. Kaleva, I. M. Schmidt, M. Chellakooty, H. E. Virtanen, K. A. Boisen, I. N. Damgaard, C. M. Kai, N. E. Skakkebaek, et al. Hormonal Changes in 3-Month-Old Cryptorchid Boys J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 953 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. I. Agoulnik Cryptorchidism--An Estrogen Spoil? J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4975 - 4977. [Full Text] [PDF]
|
|
|
|
|
|
R. Yoshida, M. Fukami, I. Sasagawa, T. Hasegawa, N. Kamatani, and T. Ogata Association of Cryptorchidism with a Specific Haplotype of the Estrogen Receptor {alpha} Gene: Implication for the Susceptibility to Estrogenic Environmental Endocrine Disruptors J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4716 - 4721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.T. Preiksa, B. Zilaitiene, V. Matulevicius, N.E. Skakkebaek, J.H. Petersen, N. Jorgensen, and J. Toppari Higher than expected prevalence of congenital cryptorchidism in Lithuania: a study of 1204 boys at birth and 1 year follow-up Hum. Reprod., July 1, 2005; 20(7): 1928 - 1932. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Delbes, C. Levacher, C. Duquenne, C. Racine, P. Pakarinen, and R. Habert Endogenous Estrogens Inhibit Mouse Fetal Leydig Cell Development via Estrogen Receptor {alpha} Endocrinology, May 1, 2005; 146(5): 2454 - 2461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ferlin, A. Garolla, A. Bettella, L. Bartoloni, C. Vinanzi, A. Roverato, and C. Foresta Androgen receptor gene CAG and GGC repeat lengths in cryptorchidism Eur. J. Endocrinol., March 1, 2005; 152(3): 419 - 425. [Abstract] [Full Text] [PDF]
|
|